Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0ZP0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $119,535
Award facts
- Contract value 100% obligated
- $119,535.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $119,535.29 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Dupixent 300 mg/2 mL pen injectors. This non-competitive delivery order, valued at approximately $120K, represents a single task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be completed by January 9, 2026, with performance taking place at the company's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication commonly used to treat moderate-to-severe atopic dermatitis, eosinophilic conditions, and asthma, making this delivery critical for military healthcare system requirements.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs through extensive contracts with the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company holds a prime Indefinite Delivery/Indefinite Quantity contract with DLA valued at up to $999,999,999.00 through December 2026, which serves as the overarching vehicle enabling the delivery of comprehensive pharmaceutical products and medical supplies globally to support military healthcare operations. This delivery order demonstrates the contractor's ongoing role as a critical supplier of specialty medications and biologics to the federal government's military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F0ZP0?
SPE2DR26F0ZP0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F0ZP0 worth?
The government has obligated $119,535 on SPE2DR26F0ZP0.
Is contract SPE2DR26F0ZP0 an order under another contract?
Yes. SPE2DR26F0ZP0 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0ZP0 competed?
The extent of competition for SPE2DR26F0ZP0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award